SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jemal A, Thomas A, Murray T, Thun M. Cancer statistics 2002. CA Cancer J Clin. 2002; 52: 2347.
  • 2
    Linet MS, Cartwright RA. The leukemias. In: SchottenfeldD, FraumeniJFJr. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996: 841892.
  • 3
    Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL. Trends in cancer incidence among children in the United States. Cancer. 1996; 78: 532541.
  • 4
    Linet MS, Ries LAG, Smith MA, Taron ED, Devesa SS. Recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst. 1999; 91: 10511058.
  • 5
    Blair V, Birch JM. Patterns and temporal trends in the incidence of malignant disease in children: I. Leukemia and lymphoma. Eur J Cancer. 1994; 30A: 14901498.
  • 6
    Kaatsch P, Haaf G, Michaelis J. Childhood malignancies in Germany — methods and results of a nationwide registry. Eur J Cancer. 1995; 31A: 993999.
  • 7
    McNally RJQ, Blair JM, Taylor M, Eden OB. Incidence of childhood precursor B-cell acute lymphoblastic leukaemia in northwest England. Lancet. 2000; 356: 485486.
  • 8
    McNally RJQ, Cairns DP, Eden OB, Kelsey AM, Taylor GM, Birch JM. Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues. Leukemia. 2001; 15: 16121618.
  • 9
    Wingo PA, Ries LAG, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973–1995. A report card for the United States. Cancer. 1998; 82: 11971207.
  • 10
    McNally RJQ, Roman E, Cartwright RA. Leukemias and lymphomas: time trends in the UK, 1984-1993. Cancer Causes Control. 1999; 10: 3542.
  • 11
    McNally RJQ, Rowland D, Roman E, Cartwright RA. Age and sex distributions of hematological malignancies in the U.K. Hematol Oncol. 1997; 15: 173189.
  • 12
    Groves FD, Linet MS, Devesa SS. Patterns of occurrence of the leukaemias. Eur J Cancer. 1995; 31A: 941949.
  • 13
    Surveillance, Epidemiology, and End Results (SEER) program public-use data (1973–1998). Bethesda: National Cancer Institute, 2001.
  • 14
    Percy C, Van Holten V, Muir C. International classification of diseases for oncology (2nd edition). Geneva: World Health Organization, 1992.
  • 15
    Kleinbaum DH, Kupper LL, Muller KE. Applied regression analysis and other multivariate methods (2nd edition). Boston: PWS-Kent, 1988.
  • 16
    Hollander M, Wolfe DA. Nonparametric statistical methods (2nd edition). New York: Wiley & Sons, Inc., 1999.
  • 17
    Clevand WS, Devlin SJ. Locally-weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc. 1988; 83: 596610.
  • 18
    Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States. A geographical analysis of cases from the pediatric cooperative clinical trials groups. Cancer. 1996; 77: 201207.
  • 19
    Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta B. Long term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994. Leukemia. 2000; 14: 22762286.
  • 20
    Gaynon PS, Trigg ME, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Leukemia. 2000; 14: 22232233.
  • 21
    Perentesis JP. Why is age such an important risk factor in acute lymphoblastic leukemia? Leukemia. 1997; 4 (Suppl): S4S7.
  • 22
    Stock W, Sather H, Dodge RK, et al. Outcome of adolescents and young adults with ALL: a comparison of Children's Cancer Group and Cancer and Leukemia Group B regimens. Blood. 2000; 96: 476a.
  • 23
    Head DR. Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful? Curr Opin Oncol. 2002; 14: 1923.